Posted on June 5, 2009 by cartier@bio
The National Institutes of Health unveiled two new grant programs this week for small research companies that will be supported by stimulus funds provided to the NIH under the American Recovery & Reinvestment Act of 2009. “These new programs will help provide much-needed resources to biotech companies, who are at the cusp of many medical [...]
Filed under: BIO, Uncategorized | Tagged: BIO, financing, NIH, Small Business | Leave a Comment »
Posted on April 27, 2009 by cartier@bio
A two-time cancer survivor and a perennial Republican swing voter, Senator Arlen Specter (R-PA), urged the creation of the Cures Acceleration Network, a new agency to provide grants to help biotech companies develop new treatments, reports Reuters and The Boston Globe:
I believe that we can live not only longer lives, but healthier lives, by harnessing [...]
Filed under: Congress, Finding Cures, In the News, Uncategorized | Tagged: Cures Acceleration Network, Specter | Leave a Comment »
Posted on April 24, 2009 by cartier@bio
Josh Green, general partner at MDV-Mohr Davidow Ventures and three entrepreneurs visited Capitol Hill on Wednesday to testify before the House Small Business Committee about the need to reauthorize the SBIR program.
The Wall Street Journal’s Venture Capital Dispatch blog reported,
“Companies receiving venture funding may have other innovation in the pipeline worth [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, House Small Business Committee, SBIR, venture capital | 1 Comment »
Posted on April 2, 2009 by cartier@bio
The economic news this week wasn’t all doom and gloom – Google announced Google Ventures, a new venture capital fund that will finance biotechnology start ups, among other things.
According to Google Blog:
At its core, Google Ventures is charged with finding and helping to develop exceptional start-ups. We’ll be focusing on early stage investments across [...]
Filed under: BIO, In the News, venture capital | Tagged: biotechnology, Google, Innovation, start-up, VC, venture capital | Leave a Comment »
Posted on November 6, 2008 by cartier@bio
Following the conclusion to a dramatic election season, BIO President and CEO Jim Greenwood offered his congratulations to President-Elect Barack Obama.
Recognizing the challenges that the next President will face Greenwood stated in a release yesterday:
From health care to energy to climate change to environmental sustainability, President-elect Obama will enter office facing a daunting [...]
Filed under: Uncategorized | 1 Comment »
Posted on July 31, 2008 by cartier@bio
WASHINGTON, July 30, 2008 — Small businesses that are majority-backed by venture capital, many of which are producing biotech therapies and cures, will be eligible for a portion of Small Business Innovation Research (SBIR) grants under a bill reported out of the Senate Committee on Small Business today. The bill reauthorizes the SBIR program for [...]
Filed under: Uncategorized | Leave a Comment »
Posted on July 25, 2008 by cartier@bio
According to Trading Markets:
MARKUP NOTICE
For July 30, 2008
The Committee on Small Business and Entrepreneurship will hold a public markup of a bill to reauthorize the Small Business Innovation Research (SBIR) Program on Wednesday, July 30, 2008 at 11:30 a.m., in room 428A Russell Senate Office Building.
All agencies with an extramural research and development budget exceeding [...]
Filed under: Uncategorized | Leave a Comment »
Posted on May 9, 2008 by cartier@bio
Washington Business Journal
The House passed legislation that would make small businesses majority-owned by venture capital firms eligible for Small Business Innovation Research awards.
Through the SBIR program, 2.5 percent of the outside research budgets of 11 federal agencies — including the Department of Defense and the National Institutes of Health — is allocated for small [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, NIH, SBIR, small business innovation, Washington Business Journal | Leave a Comment »